IE1

Helocyte, Inc. Announces Positive Data from Stem Cell Transplant Donor Vaccination Trial to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Retrieved on: 
Thursday, February 16, 2023

MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Helocyte, Inc., (“Helocyte”) a subsidiary company of Fortress Biotech, Inc. (Nasdaq: FBIO), announced today that data from a Phase 1 pilot trial (see NCT03560752) evaluating the potential safety, immunological response and efficacy of the cytomegalovirus (“CMV”) vaccine Triplex to enhance CMV protective immunity in immunosuppressed recipients of allogeneic hematopoietic cell transplants (“HCT”) will be presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (“Tandem Meetings”), taking place February 15-19, 2023, in Orlando, Florida. Triplex was developed by City of Hope, one of the largest cancer research and treatment organizations in the United States, and exclusively licensed to Helocyte in 2015.

Key Points: 
  • City of Hope researchers led a pilot trial to explore the vaccination of immunocompetent HCT donors with Triplex to enhance CMV protective immunity in recipients of an allogeneic HCT.
  • “CMV is still the most common infectious complication in allogeneic HCT and remains of fundamental clinical concern.
  • Triplex was generally well-tolerated in stem cell donors who participated in the study with no serious adverse events reported.
  • All HCT recipients were fully engrafted with stem cells of donor origin without delay.

Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of Cytomegalovirus in Patients Undergoing Liver Transplantation

Retrieved on: 
Thursday, August 11, 2022

This competitive award will fund a multi-center, placebo-controlled, randomized Phase 2 study of Triplex for control of CMV in patients undergoing liver transplantation.

Key Points: 
  • This competitive award will fund a multi-center, placebo-controlled, randomized Phase 2 study of Triplex for control of CMV in patients undergoing liver transplantation.
  • Triplex was developed by City of Hope, one of the largest cancer research and treatment organizations in the United States.
  • Helocyte secured an exclusive worldwide license to Triplex from City of Hope in 2015.
  • The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Global Induction Motor Market Trends, Forecast and Competitive Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 5, 2022

The "Induction Motor Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Induction Motor Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The major growth drivers for this market are factors driving the induction motor market include economical cost and low maintenance of the induction motors.
  • Some of the induction motor companies profiled in this report include Nidec Motor Corporation, ABB, Siemens, WEG Electric Corp, Emerson Electric Co., Ametek, Baldor Electric, Brook Crompton, Johnson Electric Holdings and Regal Beloit and others
    This report answers the following 11 key questions:
    Q.1 What are some of the most promising potential, high-growth opportunities for the induction motor market by supply phase (single phase induction motor and three phase induction motor), end use industry (residential, industrial, and commercial), efficiency class (IE1, IE2, IE3, and IE4), and region (APAC, North America, Europe, and ROW)?
  • Q.11 What M & A activities have taken place in the last 5 years in this, induction motor market?

Low Voltage Motors Market Growth to Nearly Double amid Surging Application in Automotive and HVAC Systems

Retrieved on: 
Friday, November 19, 2021

NEW YORK, Nov. 19, 2021 /PRNewswire/ -- As per the newly released data by Fact.MR analysis, the global low voltage motors market size is expected to reach US$ 36.6 Bn by the end of 2021. Global sales of low voltage motors are projected to rise at 6.8% CAGR, with overall valuation reaching around US$ 70.6 Bn by 2031.

Key Points: 
  • Increasing adoption of low voltage motors across various applications such as pumps, fans, compressors and automotive is driving the low voltage motor market.
  • Swift transition of energy sector from fuel powered motors to green and efficient technologies is creating a plethora of opportunities for growth within the low voltage motors market.
  • Low voltage motors offer various advantages such as long operating life, low maintenance cost and high energy efficiency.
  • To learn more about Low Voltage Motors Market, you can get in touch with our Analyst at
    Leading companies operating in low voltage motors market are focusing on developing advanced products integrated with modern technologies.

Low Voltage Motors Market Growth to Nearly Double amid Surging Application in Automotive and HVAC Systems

Retrieved on: 
Friday, November 19, 2021

Increasing adoption of low voltage motors across various applications such as pumps, fans, compressors and automotive is driving the low voltage motor market.

Key Points: 
  • Increasing adoption of low voltage motors across various applications such as pumps, fans, compressors and automotive is driving the low voltage motor market.
  • Swift transition of energy sector from fuel powered motors to green and efficient technologies is creating a plethora of opportunities for growth within the low voltage motors market.
  • As low voltage motors are energy efficient and comply with governmental guidelines, they are being increasingly adopted in HVAC systems.
  • To learn more about Low Voltage Motors Market, you can get in touch with our Analyst at
    Leading companies operating in low voltage motors market are focusing on developing advanced products integrated with modern technologies.